Now, quick fix drug to tackle obesity, diabetes!
- Gujjars intensify agitation for job quota, block Delhi-Mumbai rail track
- Video: Mumbai graduate denied job for being Muslim, Minorities Commission seeks explanation from company
- Geelani's 'incomplete' passport application cannot be processed: MEA
- Manish Sisodia launches counter-attack, says AAP govt trying to stop officers' transfer-posting industry
- 'You are the apple of my eye': Osama bin Laden's son's letter to wife
Here's some good news for those looking for a "quick-fix" to shed flab -- scientists claim to have developed a "four-in-one" diet drug which reduces weight, apart from controlling blood pressure, cholesterol levels and even preventing diabetes, particularly in obese.
The jab, liraglutide, which could be available in the market in three years, has a "feel-good" factor – similar in structure to a gut hormone that helps regulate appetite, it tricks brain into thinking people are full despite eating 20 per cent less food, the 'Daily Mail' reported.
The scientists tested liraglutide on more than 550 obese men and women. Some of those taking part were given liraglutide daily. Others were given a supply of dummy pills.
Those who took liraglutide lost an average of a stone and a half over six months -- more than twice as much as those on dummy drugs. When they took the drug for another 18 months, the weight stayed off. However those on dummy pills started to pile the pounds back on, say the scientists.
The benefits of liraglutide, which like insulin comes in an injectable pen, did not end there. Blood pressure levels dropped to such an extent that patients could throw away the drugs they were taking to keep it under control. There was also an improvement in blood fats, including cholesterol.
The body's ability to deal with sugar changed so much that diabetes was staved off in those at risk. Liraglutide can also improve the processing of sugar in those who already have the condition -- removing need for some to inject themselves with insulin, according to the scientists.
Prof Mike Lean of Glasgow University, who treated some of the Britons in the trial, said: "The weight loss was very striking. One of the things we looked at was prediabetes where you have one foot on the slippery slope towards diabetes and heart disease, and it more or less abolished it. That doesn't mean that it has gone forever but at least you've turned the clock back."